Literature DB >> 11044273

Household costs of 'malaria' morbidity: a study in Matale district, Sri Lanka.

N Attanayake1, J Fox-Rushby, A Mills.   

Abstract

Short-run economic consequences of 'malaria' on households were examined in a household survey in Matale, a malaria-endemic district of Sri Lanka. On average a household incurred a total cost of Rs 318 (US$ 7) per patient who fully recovered from 'malaria'. 24% of this was direct cost, 44% indirect cost for the patient and 32% indirect cost for the household. Direct costs were greater for those seeking treatment in the private sector. Notably a large proportion of direct costs was spent on complementary goods such as vitamins and foods considered to be nutritional. Indirect cost was measured and valued on the basis of output/ income losses incurred at the household level rather than using a general indicator such as average wage rate. Loss of output and wages accounted for the highest proportion of the indirect cost of the patients as well as the households. Relative to children, more young adults and middle-aged people had 'malaria' which also caused greater economic loss in these age groups. Women tended to care for patients rather than substitute their labour to cover productive work lost due to illness. We compare the methods used by other researchers for valuing indirect cost, demonstrating the significant impact that methods of measurement and valuation can have on the estimation of indirect cost, and justify the recommendation for methodological research in this area.

Entities:  

Mesh:

Year:  2000        PMID: 11044273     DOI: 10.1046/j.1365-3156.2000.00612.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  29 in total

1.  Determinants of household direct and indirect costs: an insight for health-seeking behaviour in Burkina Faso.

Authors:  Tin Tin Su; Steffen Flessa
Journal:  Eur J Health Econ       Date:  2011-09-28

Review 2.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 3.  Plasmodium vivax treatments: what are we looking for?

Authors:  Ric N Price; Nicholas M Douglas; Nicholas M Anstey; Lorenz von Seidlein
Journal:  Curr Opin Infect Dis       Date:  2011-12       Impact factor: 4.915

4.  Hidden burden of non-medical spending associated with inpatient care among the poor in Afghanistan.

Authors:  Mohammad Omar Mashal; Keiko Nakamura; Masashi Kizuki
Journal:  Int J Public Health       Date:  2016-05-18       Impact factor: 3.380

5.  The Investment Case for Malaria Elimination in Thailand: A Cost-Benefit Analysis.

Authors:  Prayuth Sudathip; Darin Kongkasuriyachai; Rachel Stelmach; Donal Bisanzio; Jeffrey Sine; Surasak Sawang; Suravadee Kitchakarn; David Sintasath; Richard Reithinger
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

Review 6.  Artemisinin combination therapy for vivax malaria.

Authors:  Nicholas M Douglas; Nicholas M Anstey; Brian J Angus; Francois Nosten; Ric N Price
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

7.  The economic costs of malaria in four Kenyan districts: do household costs differ by disease endemicity?

Authors:  Jane Chuma; Vincent Okungu; Catherine Molyneux
Journal:  Malar J       Date:  2010-06-02       Impact factor: 2.979

8.  The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Authors:  Brian K Chu; Pamela J Hooper; Mark H Bradley; Deborah A McFarland; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

Review 9.  Reviewing the literature on access to prompt and effective malaria treatment in Kenya: implications for meeting the Abuja targets.

Authors:  Jane Chuma; Timothy Abuya; Dorothy Memusi; Elizabeth Juma; Willis Akhwale; Janet Ntwiga; Andrew Nyandigisi; Gladys Tetteh; Rima Shretta; Abdinasir Amin
Journal:  Malar J       Date:  2009-10-28       Impact factor: 2.979

10.  Effect of removing direct payment for health care on utilisation and health outcomes in Ghanaian children: a randomised controlled trial.

Authors:  Evelyn Korkor Ansah; Solomon Narh-Bana; Sabina Asiamah; Vivian Dzordzordzi; Kingsley Biantey; Kakra Dickson; John Owusu Gyapong; Kwadwo Ansah Koram; Brian M Greenwood; Anne Mills; Christopher J M Whitty
Journal:  PLoS Med       Date:  2009-01-06       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.